Cathie Wood Sheds $5M In CRISPR Therapeutics, Scoops Up These Biotech Stocks Instead

Benzinga2022-08-05

Cathie Wood-led Ark Investment Management on Thursday sold 70,723 shares of gene editing company CRISPR Therapeutics AG, valued at over $5.58 million, via its flagship fund.For ARK Innovation ETF, ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

Dave0123
2022-08-05
Dave0123
Ok
CIG
2022-08-05
CIG
Biotech companies are time bombs, may explode many times, or vanish into nothing.
MrHuattt
2022-08-05
MrHuattt
Okay
JLCH
2022-08-05
JLCH
yo

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1191398251?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2022-08-05 15:33","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1191398251","market":"us","top_or_hot":-1,"title":"Cathie Wood Sheds $5M In CRISPR Therapeutics, Scoops Up These Biotech Stocks Instead","media":"Benzinga","content":"<div>\n<p>Cathie Wood-led Ark Investment Management on Thursday sold 70,723 shares of gene editing company CRISPR Therapeutics AG, valued at over $5.58 million, via its flagship fund.For ARK Innovation ETF, ...</p>\n\n<a href=\"https://www.benzinga.com/news/22/08/28369047/cathie-wood-run-ark-innovation-etf-sells-crispr-therapeutics-loads-up-on-exact-sciences-corporation\">Source Link</a>\n\n</div>\n","source":"lsy1606299360108","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Cathie Wood Sheds $5M In CRISPR Therapeutics, Scoops Up These Biotech Stocks Instead</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCathie Wood Sheds $5M In CRISPR Therapeutics, Scoops Up These Biotech Stocks Instead\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-08-05 15:33 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.benzinga.com/news/22/08/28369047/cathie-wood-run-ark-innovation-etf-sells-crispr-therapeutics-loads-up-on-exact-sciences-corporation><strong>Benzinga</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Cathie Wood-led Ark Investment Management on Thursday sold 70,723 shares of gene editing company CRISPR Therapeutics AG, valued at over $5.58 million, via its flagship fund.For ARK Innovation ETF, ...</p>\n\n<a href=\"https://www.benzinga.com/news/22/08/28369047/cathie-wood-run-ark-innovation-etf-sells-crispr-therapeutics-loads-up-on-exact-sciences-corporation\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"CRSP","symbol_name":"CRISPR Therapeutics AG","start_time":0,"source_url":"https://www.benzinga.com/news/22/08/28369047/cathie-wood-run-ark-innovation-etf-sells-crispr-therapeutics-loads-up-on-exact-sciences-corporation","article_id":"1191398251","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1191398251","pubTimestamp":1659684788,"sourceInfo":{"source_id":"lsy1606299360108","name":"Benzinga"},"weMediaInfo":null,"summary":"Cathie Wood-led Ark Investment Management on Thursday sold 70,723 shares of gene editing company CRI","collect":0,"end_time":0,"defaultTopTitle":"benzinga.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"CRSP":"CRISPR Therapeutics AG"},"translate_title":"凯茜·伍德在CRISPR治疗公司抛售500万美元，转而收购这些生物技术股票","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CRSP":0.9},"content_text":"Cathie Wood-led Ark Investment Management on Thursday sold 70,723 shares of gene editing company CRISPR Therapeutics AG, valued at over $5.58 million, via its flagship fund.For ARK Innovation ETF, CRISPR is its fifth largest holding with a weight of 4.83%, according to holdings data on the firm's website as of Thursday.Analyst Rating: Citigroup has increased the price target on the firm’s shares to $83, while maintaining a \"neutral\" rating.Stock Movement: The stock ended Thursday up 0.42% at $78.91.The flagship fund currently holds over 6 million shares in CRISPR valued at over $493 million. During the end of July, its CEO Samarth Kulkarni sold 25,000 shares, SEC filings showed.Other Trades: ARKK bought 28,048 shares of cancer diagnostics firm EXACT Sciences Corporation, valued at over $1.38 million based on the stock's last close. EXACT Sciences is the sixth largest holding of the fund at a weight of 4.66%. The stock closed 3.72% higher on Thursday.The fund also bought 113,483 shares of Pacific Biosciences of California Inc shares, valued at over $650,000 as of Thursday’s close.The fund currently holds over 13.8 million shares in the firm valued at over $72 million, with a weight of 0.71%. Pacific Biosciences shares ended 11.52% higher at $5.81 on Thursday.","kind":"news","is_publish_news":true,"is_publish_highlight":true,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":9902663774,"gmtCreate":1659688723300,"gmtModify":1704885013860,"author":{"id":"4097750570226740","authorId":"4097750570226740","name":"Dave0123","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"hat":"https://static.tigerbbs.com/b0a2963eb37c60c5d6d4a8dbcd266952","crmLevel":7,"crmLevelSwitch":0,"idStr":"4097750570226740","authorIdStr":"4097750570226740"},"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9902663774","repostId":1191398251,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9902681337,"gmtCreate":1659686739231,"gmtModify":1704870120986,"author":{"id":"3583974841960176","authorId":"3583974841960176","name":"CIG","avatar":"https://static.tigerbbs.com/6c2077e2370e1ffcaca7e29b875be2be","vip":1,"hat":"https://static.tigerbbs.com/f84d87792f02cf78e80ee34979fd31e5","crmLevel":5,"crmLevelSwitch":1,"idStr":"3583974841960176","authorIdStr":"3583974841960176"},"htmlText":"Biotech companies are time bombs, may&nbsp;explode many times, or vanish into nothing.","listText":"Biotech companies are time bombs, may&nbsp;explode many times, or vanish into nothing.","text":"Biotech companies are time bombs, may explode many times, or vanish into nothing.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9902681337","repostId":1191398251,"repostType":2,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9902617510,"gmtCreate":1659686094032,"gmtModify":1704865974801,"author":{"id":"4089116574465250","authorId":"4089116574465250","name":"MrHuattt","avatar":"https://community-static.tradeup.com/news/e67f8f8c2b0192fadc4cd499a84e6c8b","vip":1,"crmLevel":5,"crmLevelSwitch":1,"idStr":"4089116574465250","authorIdStr":"4089116574465250"},"htmlText":"Okay","listText":"Okay","text":"Okay","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9902617510","repostId":1191398251,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9902614687,"gmtCreate":1659685802353,"gmtModify":1704865452996,"author":{"id":"3572670964273182","authorId":"3572670964273182","name":"JLCH","avatar":"https://static.tigerbbs.com/37f9208a53c3a3c582fb50de5cde53d4","vip":1,"hat":"https://static.tigerbbs.com/4c5ceab71416b120bab4604c0754b52a","crmLevel":5,"crmLevelSwitch":0,"idStr":"3572670964273182","authorIdStr":"3572670964273182"},"htmlText":"yo","listText":"yo","text":"yo","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9902614687","repostId":1191398251,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"}],"isCommentEnd":false,"newsSizeData":{"likeSize":60,"commentSize":4,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1191398251"}